Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 12/31/12
Due: 12/31/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris | NCT02160678 | G & W Laboratories Inc. | user2@example.com | None | 2014-05-31 | 2015-07-31 | 2016-07-31 | - | - | 2025-07-14 |
| Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids | NCT01913158 | G & W Laboratories Inc. | user2@example.com | None | 2013-10-31 | 2014-03-31 | 2015-03-31 | - | - | 2025-07-14 |
| Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis | NCT02160665 | G & W Laboratories Inc. | user2@example.com | None | 2014-05-31 | 2016-05-31 | 2017-05-31 | - | - | 2025-07-14 |
| Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing | NCT01447680 | G & W Laboratories Inc. | user2@example.com | None | 2011-08-31 | 2012-12-31 | 2013-12-31 | - | - | 2025-07-14 |